TIMI 11BResults: Early Treatment Phase

0

1

2

3

4

5

6

7

8

9

0

8

16

24

32

40

48

56

64

72

% Patients

Hours from Randomization

7.3 %

5.5 %

RRR 24%

P=0.026

UFH

Enoxaparin

Antman EM, et al. Circulation 1999;100:1593-1601.

Previous slide Next slide Back to first slide View graphic version